Reining in prescription drug costs

Marie Waldron
Marie Waldron. Valley News/Courtesy photo
Assemblymember Marie Waldron Special to Valley News One of the most important lessons from the pandemic is the need to prioritize reliable prescription drug manufacturing. California, especially this region, has long been a center for medical research, and one of our top priorities should be to encourage more drug research, innovations and manufacturing, especially for generic drugs. That’s why I support Senate Bill 852. While the main benefit of SB 852 will be to make medication available for thousands of Californians at a more reasonable cost, as we emerge from the pandemic-induced recession we can also create thousands of new jobs to help restore the world’s fifth-largest economy. SB 852 requires the California Health and Human Services Agency to enter into partnerships
Subscribe or log in to read the rest of this content.